This year we have adapted and evolved to incorporate other pivotal areas that have to be considered in any meaningful treatise of opioids. It is imperative that we examine these non-opioids so that we do not allow the demonisation of opioids to force us to embrace cannabinoids and gabapentinoids as the saviours of analgesia before we have had the chance to forensically examine their benefit and possible harms.